NewAmsterdam Pharma Co NV (NAMS) PT Raised to $45 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Roanna Ruiz raised the price target on NewAmsterdam Pharma Co NV (NASDAQ: NAMS) to $45.00 (from $42.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
